This study, through single‐cell sequencing bioinformatics analysis [17], first identified CTHRC1 as specifically overexpressed in pancreatic cancer CAFs, with its expression significantly correlated to poor patient prognosis. This evidence concerns the gene CTHRC1 and pancreatic neoplasm.